Performance. Defined.

InVitria Blog | Cell Culture and Biotech Manufacturing Insights

Attie Pennybaker

Attie Pennybaker
Atherly Pennybaker joined InVitria in 2017 as a Product Applications Specialist after receiving her Bachelor of Science in Chemical and Biological Engineering from Colorado State University. During her time there, she conducted undergraduate research in tissue engineering where she co-authored a paper on the osteoinductivity of an engineered biomimetic periosteum. She also worked on the design of a natural cell and tissue scaffold by means of electrospinning demineralized bone matrix. At InVitria she enjoys leveraging her scientific background to help customers successfully transition to blood-free, chemically defined systems.
Find me on:

Recent Posts

Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture

Posted By Attie Pennybaker on 3/4/19 12:30 PM

ITSE App Note #1 Download CTA ButtonWorkflow Summary:

Supplement basal media with ITSE + A to a final 1x-2x concentration. Reduce typical percentage of added FBS by 50-90%. Expand cells as normal in ITSE + A supplemented media for desired expansion time. Perform post-expansion cell count and doubling-time calculation.

Read More

InVitria's Top Insights from ISCT 2018 - Montreal

Posted By Attie Pennybaker on 5/15/18 4:00 PM

The International Society of Cell & Gene Therapy (ISCT) has a rich history of bringing together leading professionals who are committed to advancing the field. This year, from May 2nd to May 5th, nearly 1500 of those leading professionals from across the globe gathered in the bustling Canadian city of Montreal to share the latest breakthroughs and innovations, partake in thought-provoking conversations, and create lasting connections at the ISCT 2018 annual conference. Although I did not get a chance to indulge in the famed Canadian poutine dish, I left the country full of something better: new ideas, deeper knowledge, and a greater appreciation for the potential implications and benefits of cell and gene therapy innovation.

Read More

3 Takeaways from the World Vaccine Congress 2018

Posted By Attie Pennybaker on 4/11/18 10:16 AM

Innovation, technology, and success has driven the vaccine industry to remain at the forefront of biotechnology and this year’s World Vaccine Congress was no exception. Taking place April 2-5 in Washington D.C., the 18th annual World Vaccine Congress lured over 1000 attendees from more than 300 leading global institutions to deliver the largest establishment of this event yet. Being surrounded by such a vast amount of knowledge and key influencers, my experience representing InVitria here was one full of inspiration.

Read More

Subscribe to our Blog:

Follow InVitria: